Search Login Register

Giant Lymph Node Hyperplasia (Castleman's Disease) Summary

Description: Large benign, hyperplastic lymph nodes. The more common hyaline vascular subtype is characterized by small hyaline vascular follicles and interfollicular capillary proliferations. Plasma cells are often present and represent another subtype with the plasma cells containing IgM and IMMUNOGLOBULIN A.

Also Known As: Castleman's Disease; Angiofollicular Lymphoid Hyperplasias; Castleman Tumor; Castlemans Disease; Castlemans Tumor Show All >>

Networked: 535 relevant articles (50 outcomes, 20 trials/studies) for this Disease

Key Drugs and Agents for Giant Lymph Node Hyperplasia

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. tocilizumab : 14 outcomes 6 studies in 35 results : FDA 2
  2. rituximab (Mabthera) : 11 outcomes in 34 results : FDA 3
  3. Interleukin-6 (Interleukin 6) : 10 outcomes 6 studies in 112 results : IBA
  4. Interleukin-6 Receptors (Interleukin 6 Receptor) : 3 outcomes 1 study in 12 results : IBA
  5. Thalidomide (Thalomid) : 3 outcomes in 12 results : FDA 2
  6. bortezomib (Velcade) : 2 outcomes in 4 results : FDA 1
  7. Antibodies : 1 outcome 1 study in 8 results : IBA
  8. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor) : 1 outcome in 14 results : IBA
  9. Iron : 1 outcome in 5 results : IBA
  10. lenalidomide (CC 5013) : 1 outcome in 4 results : FDA 2
Show All >>

Diseases Related to Giant Lymph Node Hyperplasia

  1. Rheumatoid Arthritis
  2. Juvenile Rheumatoid Arthritis (Juvenile Idiopathic Arthritis)
  3. Kaposi Sarcoma (Kaposi's Sarcoma)
  4. Anemia
  5. Crohn Disease (Crohn's Disease)
Show All >>

Key Therapies for Giant Lymph Node Hyperplasia

Efficacy Chart >>
  1. Radiotherapy : 3 outcomes 2 studies in 13 results
  2. Drug Therapy (Chemotherapy) : 2 outcomes in 16 results
  3. Combination Drug Therapy (Combination Chemotherapy) : 2 outcomes in 3 results
  4. Highly Active Antiretroviral Therapy (HAART) : 1 outcome in 7 results
  5. Aftercare (After-Treatment) : 1 outcome in 3 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.